111 related articles for article (PubMed ID: 3756069)
1. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
Br J Clin Pharmacol; 1986 Aug; 22(2):201-2. PubMed ID: 3756069
[No Abstract] [Full Text] [Related]
2. Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.
Jones CR; Pasanisi F; Elliott HL; Reid JL
Br J Clin Pharmacol; 1985 Sep; 20(3):191-6. PubMed ID: 2994701
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Rostagno C; Abbate R; Gensini GF; Coppo M; Prisco D; Boddi M; Neri Serneri GG
Thromb Res; 1991 Aug; 63(4):457-62. PubMed ID: 1754998
[No Abstract] [Full Text] [Related]
4. Voltage clamp comparison of the organic calcium channel blockers D-600 and nisoldipine.
Uehara A; Hume JR
Proc West Pharmacol Soc; 1984; 27():343-7. PubMed ID: 6494173
[No Abstract] [Full Text] [Related]
5. The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.
Francis JL; Roath OS; Challenor VF; Waller DG
Br J Clin Pharmacol; 1988 Jun; 25(6):751-4. PubMed ID: 3203045
[TBL] [Abstract][Full Text] [Related]
6. Comparative electrophysiologic and coronary hemodynamic effects of diltiazem, nisoldipine and verapamil on myocardial tissue.
Lathrop DA; Valle-Aguilera JR; Millard RW; Gaum WE; Hannon DW; Francis PD; Nakaya H; Schwartz A
Am J Cardiol; 1982 Feb; 49(3):613-20. PubMed ID: 7058769
[No Abstract] [Full Text] [Related]
7. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
Schrör K; Latta G; Darius H; Klaus W; Ziegler R
Klin Wochenschr; 1985 Jan; 63(1):16-9. PubMed ID: 3838352
[TBL] [Abstract][Full Text] [Related]
8. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Glusa E; Bevan J; Heptinstall S
Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine.
Bodewei R; Hering S; Schubert B; Wollenberger A
Biomed Biochim Acta; 1987; 46(8-9):S688-90. PubMed ID: 2449201
[TBL] [Abstract][Full Text] [Related]
10. Studies on the comparative coronary vasodilator, vasodepressor and antiarrhythmic actions of gallopamil (D-600) and nisoldipine (Bay K 5552).
Basu DK; Brahmankar DM
Mater Med Pol; 1985; 17(2):103-6. PubMed ID: 4079466
[No Abstract] [Full Text] [Related]
11. Anti-aggregatory actions of calcium channel blockers in cat platelets.
Schmunk GA; Lefer AM
Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):179-87. PubMed ID: 6803310
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium channel blockers on arachidonate-induced sudden death in rabbits.
Okamatsu S; Peck RC; Lefer AM
Proc Soc Exp Biol Med; 1981 Apr; 166(4):551-5. PubMed ID: 6261265
[No Abstract] [Full Text] [Related]
13. Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
Rostagno C; Prisco D; Paniccia R; Costanzo G; Poggesi L; Boddi M; Abbate R
Thromb Res; 1990 Aug; 59(3):531-9. PubMed ID: 2237825
[TBL] [Abstract][Full Text] [Related]
14. Membrane activity, antioxidant, antiaggregatory and antihemolytic properties of four calcium channel blockers.
Robak J; Duniec Z
Pharmacol Res Commun; 1986 Dec; 18(12):1107-17. PubMed ID: 3562505
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
Kiyomoto A; Sasaki Y; Odawara A; Morita T
Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
[TBL] [Abstract][Full Text] [Related]
16. [Calcium antagonists in congestive heart failure].
Barbieri L; Mestroni L; Camerini F
G Ital Cardiol; 1988 Nov; 18(11):989-96. PubMed ID: 3073994
[No Abstract] [Full Text] [Related]
17. The effects of nisoldipine, diltiazem, nifedipine, and verapamil on hemodynamic parameters and red blood cells-platelet interactions in patients with arterial hypertension.
Belousov Y; Kushnaryov V
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S32-5. PubMed ID: 1725540
[TBL] [Abstract][Full Text] [Related]
18. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
Vinge E; Andersson TL; Larsson B
Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
Hendra TJ; Oughton J; Jeremy JY; Smith CC; Betteridge DJ; Dandona P; Yudkin JS
Diabetes Res; 1988 Jul; 8(3):117-22. PubMed ID: 2976336
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons.
Meyer AC; Nieuwenhuis JJ; Kociszewska VJ; Joubert WS; Meyer BJ
Life Sci; 1986 Oct; 39(17):1563-9. PubMed ID: 3762317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
